←MRK · $148.84

Merck

MRK · Market open

$148.84

+0.15% today·exchange $148.87

exchange $148.87

Sep 18$146.15 – $152.27Sep 25

1D 1W 1M 1Y

News · Merck

Is LLY Stock Cheaper Than It Looks?
Trefis · 3h ago
Pfizer Stock Paid Out $49B: So Why Did Investors Lose Money?
Trefis · 3h ago
Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study
Zacks · 6h ago
Merck remigromig DME trial results raise safety concerns
Quartz · 6h ago
Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data
BioPharma Dive · 7h ago
Merck, Eisai Renal Cell Cancer Drug Combination Gets US FDA Approval
MT Newswires · 8h ago

Headlines from Yahoo Finance. Not investment advice.

About

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Industry: Healthcare
CEO: Robert Davis